Aurora Spine presented at the Brean Capital Life Sciences Summit Conference in New York on Nov. 24.
The company showcased several products and procedures cleared by the U.S. Food and Drug Administration. Aurora Spine focuses on developing a wide array of spinal implants, including screwless, minimally invasive and regenerative implant technologies.
More articles on devices:
Implanet pens 6 new distribution agreements — 5 quick facts on JAZZ system
Spineology receives patent for percutaneous spinal interbody fusion system
LDR to present at 2 New York-based investor conferences